#South Korea #Seoul #Cynosure #Mosaic 3D #IMCAS 2026

Cynosure Lutronic Achieves EU-MDR Approval for Mosaic 3D™

In a significant advancement for the medical aesthetic industry, Cynosure Lutronic, a global leader in energy-based technologies for medical aesthetics, has announced the achievement of EU-MDR approval for its innovative Mosaic 3D™ platform. This landmark certification marks a pivotal moment in the company's expansion and underscores its commitment to enhancing skin rejuvenation treatments on a global scale.

Mosaic 3D™ is redefining non-ablative fractional lasers with its cutting-edge technology, allowing for greater energy delivery and expansive treatment areas while maintaining high safety levels. This innovative device utilizes several advanced features that significantly reduce patient discomfort and downtime.

Cutting-Edge Features of Mosaic 3D™

3D Controlled Chaos Technology™

One of the standout features is the 3D Controlled Chaos Technology (CCT), which optimizes the distribution and penetration depth of microbeams across multiple skin layers. This technology minimizes the risk of thermal overheating, enabling a significant increase in coagulation volume per shot without compromising safety.

Integrated Cooling System

The device incorporates an integrated cooling system, allowing for safe and effective treatment of delicate areas around the eyes and mouth. The internal airflow through the handpiece and the unique sapphire tips with cold compression synergistically reduce pain, redness, and swelling, ultimately enhancing treatment effectiveness, safety, and patient comfort.

Versatile Application

Mosaic 3D™ is versatile, promoting neo-collagenesis and neo-elastinogenesis in the mid-dermis, leading to revitalized and radiant skin. By combining rolling and stamping applications in one laser platform, it facilitates efficient coverage and exceptional effectiveness.

Clinical Validation and Expert Insights

Mosaic 3D™ has received strong validation from notable international opinion leaders who are currently utilizing the device in clinical practice and ongoing research studies. Leading experts such as Dr. Guy Erlich from Israel, Professor Merete Haedersdal from Denmark, and Dr. Tatiana Kuznechenkova from the UAE have remarked on the platform's remarkable capabilities.

Dr. Erlich emphasized, "Mosaic 3D™ provides a new level of control and adaptability in fractional skin rejuvenation. Both in clinical practice and ongoing studies, we observe excellent tissue response and high treatment flexibility, making this a powerful platform for advanced skin rejuvenation indications."

Professor Haedersdal added, "In our clinical study with Mosaic™ 3D, we gained better insights into laser-tissue interactions using imaging analyses, optimizing treatment protocols for our patients with promising outcomes. We are preparing the data for publication and look forward to presenting our findings to the international medical community at IMCAS 2026."

Dr. Kuznechenkova reflected on her experience with the device, stating, "After several weeks of clinical application, Mosaic 3D™ has shown promising and highly encouraging results. Its precision and adaptability allow for highly personalized treatments, which reflects positively in both patient satisfaction and clinical outcomes."

Upcoming Events and Expanding Presence

The launch of Mosaic 3D™ was initially presented at the Cynosure Lutronic Science and Laser Symposium 2025 in Faro, where it received enthusiastic responses from industry experts. Following the EU-MDR approval and successful launches in other regions, Mosaic 3D™ is set to take center stage at the IMCAS World Congress 2026. Cynosure Lutronic will host a dedicated scientific symposium titled ‘Introducing Mosaic 3D - Redefining Non-Ablative Fractional Lasers’ led by Dr. Erlich and Professor Haedersdal on January 30th. This symposium will focus on clinical data, treatment protocols, and practical experiences with Mosaic 3D™, alongside additional educational and scientific activities throughout the congress.

Cynosure Lutronic remains committed to fostering evidence-based innovations and providing next-generation technologies that empower medical professionals and improve treatment outcomes for patients around the world. With over 55 years of combined experience in innovation and market leadership in energy-based devices, Cynosure Lutronic enables dermatologists, plastic surgeons, and aesthetic specialists worldwide to deliver non-invasive and minimally invasive treatments. The company offers one of the most comprehensive portfolios in skin rejuvenation, revitalization, hair removal, vascular treatments, skin tightening, and pigment reduction, distributed through direct sales and partners across approximately 130 countries.